Projects per year
Search results
-
Finished
Development of clinical algorithms and clinical pathways for dynamic observation of patients after COVID-19
Vīksna, L., Vanaga, I., Pētersons, A., Zeltiņa, I., Kalējs, O., Karelis, G., Rezeberga, D., Radziņa, M., Vētra, A., Storoženko, J., Taube, M., Lejnieks, A., Lietuvietis, V., Koļesova, O., Liepiņa, E., Kadiša, A., Lejniece, S., Bataraga, E., Plaudis, H., Višņakovs, A. & Bantauska, D.
Ministry of Health of the Republic of Latvia
24/05/22 → 24/11/22
Project: Contract research › R&D project
-
Assessment of new biomarkers for the prognosis and treatment prediction in chronic lymphocytic leukemia
1/04/22 → 31/03/23
Project: RSU grants
-
Fibromyalgia associated microbiome, viral infection and immunological profile
Nora-Krūkle, Z., Rasa-Dzelzkalēja, S., Ķēniņa, V., Svirskis, Š., Grāvelsiņa, S. & Vilmane, A.
1/04/22 → 31/03/23
Project: RSU grants
-
Human herpesvirus 6 chemokine receptor mediated immunomodulating mechanism involvement in autoimmune thyroiditis development
Sultanova, A., Čistjakovs, M., Sokolovska, L. & Strojeva, S.
1/12/20 → 31/12/21
Project: Fundamental and Applied Research Programme
-
Pathogenicity of human Hepatitis C virus relying on enzymatic properties of viral RNA-dependent RNA-polymerase
Issagouliantis, M., Dudorova, A. & Jansons, J.
1/12/20 → 31/12/21
Project: Fundamental and Applied Research Programme
-
Improvement of Natural Glycopeptide Isolation Technology and Studying of Their Immune-Modulating Properties (Stage II)
Saulīte, V., Černobajeva, L. & Blumfelde-Rutka, K.
Investment and Development Agency of Latvia
1/12/20 → 30/06/22
Project: EU Structural Funds › ERDF
-
The role of human herpesvirus-6 infection and alcohol abuse in the development of neuroinflammation
Skuja, S., Strojeva, S., Svirskis, Š., Blūms, D., Starta, G., Garnizone, M. & Jain, N.
1/12/20 → 31/12/21
Project: Fundamental and Applied Research Programme
-
New biomarkers for diagnosis and prognosis of calcific aortic valve stenosis
Mackēvičs, V., Tretjakovs, P., Gersone, G., Cirse, M., Bahs, G., Platkājis, A. & Svirskis, Š.
14/09/20 → 13/09/21
Project: RSU grants
-
Study of the DNA methylation degree/pattern of the PSA, PSMA and TCERG1L genes in prostate cancerous and non-cancerous cell lines
Bariševs, M., Sasoveca, I. & Maksimova, I.
14/09/20 → 13/09/21
Project: RSU grants
-
Dynamics of serum cytokines in patients with pulmonary tuberculosis
Eglīte, J., Koļesova, O., Ozere, I. & Vīksna, A.
1/08/20 → 31/07/21
Project: RSU grants
-
Establishment of COVID-19 related biobank and integrated platform for research data in Latvia
Klovins, J., Nora-Krūkle, Z., Vilne, B., Rozentāle, B., Vilmane, A., Krūmiņa, A., Terentjeva-Decuka, A., Vecvagare, K. & Vaidere, D.
1/07/20 → 31/03/21
Project: National Research Programme
-
Clinical, biochemical, immunogenetic paradigms of Covid-19 infection and their correlation with socio-demographic, etiological, pathogenetic, diagnostic, therapeutically and prognostically important factors to be included in guidelines
Vīksna, L., Leja, M., Murovska, M., Gardovska, D., Koļesova, O., Laivacuma, S., Platkājis, A., Eglīte, J., Šķesters, A., Radziņa, M., Stūre, G., Zavadska, D., Storoženko, J., Rozentāle, B., Zeltiņa, I., Koļesovs, A., Nora-Krūkle, Z., Grāvelsiņa, S., Karelis, G., Sperga, M., Plaudis, H., Arāja, D., Dzīvīte-Krišāne, I., Aleksejeva, E., Puķīte, I., Grantiņa, I., Ivanova, V., Ivanovs, A., Arutjuņana, S., Vanaga, I., Kustovs, D., Čistjakovs, M., Strojeva, S., Sokolovska, L., Meiere, A., Bajāre, L. & Vilmane, A.
1/07/20 → 30/06/21
Project: National Research Programme
-
Improving Natural Glycopeptide Isolation Technology and Studying Their Immune-Modulating Properties (Stage I)
1/04/20 → 30/09/20
Project: EU Structural Funds › ERDF
-
Differences in biochemical and immunogenetic markers of apoptosis and fibrosis and endotoxins in patients with immunosuppressive RNA virus (HIV, HCV)-induced chronic infections and their correlation to infection severity
Vīksna, L., Krūmiņa, A., Eglīte, J. & Koļesova, O.
2/09/19 → 31/03/20
Project: RSU grants
-
Study of Fullerene Nanoparticles as Adjuvants/Carriers for Vaccine Development
Sultanova, A., Čistjakovs, M., Cunskis, E., Sokolovska, L. & Strojeva, S.
1/05/19 → 31/03/20
Project: RSU grants
-
Involvement of Persistent Viral Infections in Modulation of Immune System and Development of Autoimmune Diseases
1/05/19 → 31/03/20
Project: RSU grants
-
HLA Class II alleles, levels of cytokines, and expression level of ORAI1 and STIM1 genes in blood as predictors of sputum culture conversion status in patients with different forms of tuberculosis
Eglīte, J., Koļesova, O. & Kramiča, K.
1/04/19 → 31/03/20
Project: RSU grants
-
Interplay of Environmental and Genetic Factors in the Immunologic Mechanisms of Thyroid Autoimmune Diseases
Konrāde, I., Šķesters, A., Zaķe, T., Kalere, I., Gersone, G., Upmale-Engela, S. & Svirskis, Š.
1/12/18 → 1/12/20
Project: Fundamental and Applied Research Programme
-
LIVE®VAC: New approach to active immunotherapy of Hepatitis C related cancer
1/12/18 → 28/02/21
Project: Fundamental and Applied Research Programme
-
EUROPARTNER: Strengthening and spreading international partnership activities of the Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz
Bryszewska, M., Issagouliantis, M., Lunga, A. & Jansons, J.
Polish national agency for academic exchange
1/12/18 → 15/04/22
Project: EU Programmes › Cooperation programmes
-
Investigation of the chemokine receptors CCR1 and CCR2 and EBV infection aimed on disclosure of new markers that can predict the high risk for progression of chronic lymphocytic leukemia
Holodņuka, I., Kozireva, S., Zvejniece, L., Pavlova, J. & Demida, O.
31/08/18 → 30/11/21
Project: Fundamental and Applied Research Programme
-
Human herpes virus-6 involvement in development of autoimmune thyroiditis
European Regional Development Fund, Latvia State Budget funding, Other funding source
1/09/17 → 31/08/20
Project: EU Structural Funds › ERDF
-
Studying of human parvovirus B19, bocavirus and parvovirus 4 involvement in inflammatory neurological diseases using an interdisciplinary approach
Murovska, M., Nora-Krūkle, Z., Rasa-Dzelzkalēja, S., Vilmane, A., Skuja, S. & Sūna, N.
Latvia State Budget funding, Ministry of Science and Technology of the Republic of China
2/01/17 → 30/12/19
Project: Other projects
-
EUROMENE: European network on Myalgic encephalomyelitis/Chronic fatigue syndrome
21/04/16 → 20/04/21
Project: EU Programmes › Horizon 2020
-
Development of nanostructured bone substitutes and study of immunological aspects in bone tissue regeneration
Eglīte, J. & Ločs, J.
15/02/16 → 28/02/19
Project: RSU grants
-
VACTRAIN: Twinning on DNA-Based Cancer Vaccines
Lunga, A., Issagouliantis, M. & Holodņuka, I.
1/01/16 → 31/12/18
Project: EU Programmes › Horizon 2020
-
Investigation of chemokine receptors CCR1 and CCR2 as potential diagnostic markers of B-cell malignancy progression
Holodņuka, I., Kozireva, S., Bariševs, M., Sultanova, A., Čistjakovs, M. & Lejniece, S.
1/01/14 → 31/12/17
Project: Fundamental and Applied Research Programme
-
BALTINFECT: Unlocking infectious diseases research potential at Rīga Stradiņš University
Murovska, M., Nora-Krūkle, Z. & Holodņuka, I.
Riga Stradins University, European Commission
1/09/13 → 28/02/17
Project: EU Programmes › FP7
-
Creation of a new interdisciplinary group for the development of nanotechnology based approach in cell biology with application in medicine (I)
1/01/10 → 31/12/12
Project: EU Structural Funds › ESF
-
Investigation of etiopathogenesis of chronic fatigue syndrome, post-infection and unspecified origin encephalopathy and elaboration of diagnostic criterions
1/01/09 → 1/01/12
Project: Fundamental and Applied Research Programme
-
The role of the beta-herpesviruses, HHV-6A, HHV-6B, and HHV-7, in the development of high-grade non-Hodgkin's lymphoma
1/01/09 → 31/12/12
Project: Fundamental and Applied Research Programme
-
Chemokine receptors genes in haematological malignancies
1/01/06 → 31/12/08
Project: Fundamental and Applied Research Programme
-
Involvement of the chemokine receptor gene cluster identified within the common eliminated region 1 (CER1) on human 3p21.3, in haematological malignancies and in solid tumors
1/01/01 → 31/12/03
Project: Fundamental and Applied Research Programme